Xavier Soler, MD, PhD, is an associate professor of medicine at University of California (UC) San Diego. He has recently joined GSK as an US medical affairs (USMA) physician-scientist/medical expert in respiratory. He specializes in pulmonology and sleep medicine and is the medical director of the pulmonary rehabilitation program and director of the Clinical Trials & Airway Research Center. He specializes in the diagnosis, treatment and management of chronic lung diseases, including chronic obstructive pulmonary disease (COPD) and asthma.
Dr. Soler is actively involved in education at UC medical school, as well as a clinical researcher. Most of his original work focuses on sleep disorders affecting patients with COPD. He is current investigator for the NIH-funded networks from the American Lung Association (ALA-ACRN) and the COPDGene studies. Dr. Soler is involved in studying new asthma treatments, as well as a COPD phenotype initiative that includes genotyping and state-of-the-art imaging techniques. Dr. Soler has been awarded by the American Thoracic Society (ATS) for outstanding early career investigation and also for his research contributions to the pulmonary rehabilitation field. Also, he received the UC international mentorship award in 2017. He also is involved with several initiatives to increase knowledge among physicians in respiratory medicine using new technologies.
As an associate professor in the Department of Medicine, Dr. Soler teaches medical students, residents and pulmonary fellows. He is also a lecturer in national and international meetings and serves as a reviewer for several journals, including CHEST, European Respiratory Journal, Thorax, and American Journal of Respiratory and Critical Care Medicine, etc.
Prior to his arrival at UC San Diego Health in 2006, Dr. Soler served as co-director of the Pulmonary Rehabilitation Program and co-director of the Sleep Medicine Unit at Hospital Quirón Teknon in Barcelona.